Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
According to CMS billing guidance (Medicare Article A57755), the primary covered indications are pernicious anemia, documented cobalamin deficiency with laboratory evidence, and malabsorption syndromes that prevent adequate oral B12 absorption
Research suggests it may stimulate lipolysis the process of breaking down stored fat into usable energy
Used to reconstitute this lyophilised vial before laboratory preparation
Its important to keep up with check-ups and adjust your treatment as needed
alternate days until no further improvement in neurological cases), followed by maintenance doses
US$ 21.72
US$ 29.15
US$ 24.82
US$ 27.91
